Scleroderma and facial harmonization

The short answer: scleroderma has no yes-or-no answer. The disease changes the skin, the circulation and the way tissue reacts to needles and injectable materials. For that reason, the professional generally treats the patient with extra caution, only considers the procedure when the disease is stable and depends on the rheumatologist's opinion.

What does scleroderma change in the skin and circulation?

Scleroderma is an autoimmune disease in which connective tissue becomes stiffer, and it can affect the skin locally or the body more broadly. On the face, it often shows up as tighter, shinier skin, a smaller mouth opening, thinner lips and small changes in circulation in the fingers and face. The dermis, which is the target of many treatments, no longer behaves like that of a patient without the disease.

The points that concern the professional:

• Lower elasticity: the tissue accommodates the volume of a filler less well.
• More fragile circulation: a vascular event has a smaller safety margin.
• Healing: may be slower or different from expected.
• Disease activity: an inflammatory phase increases the chance of a reaction and of worsening.
• Medications: immunosuppressants and corticosteroids alter healing and infection risk.

Which stages of the disease call for more caution?

In broad terms, the clinical literature and office practice separate three moments, which the treating doctor identifies:

This table is not a closed clinical criterion: it is a map to help you organize the conversation with the doctor and the patient.

What to ask and record in the medical history?

Beyond the standard medical history, it is worth detailing:

How to talk about expectations?

Patients with scleroderma often seek harmonization to reduce the visible effects of the disease on the face, such as a narrower mouth or loss of volume. The conversation needs to be honest: the procedure may have a limited effect, the tissue may not respond as expected and the disease keeps following its course. Promising to "restore" the face is inappropriate.

What if the doctor clears it?

Even with clearance, some approaches tend to be more prudent:

1. Start with minimal volumes and separate sessions, to observe the response.
2. Avoid combining several procedures on the same day.
3. Have hyaluronidase available when using hyaluronic acid, as with any filler.
4. Reinforce early follow-up and quick contact in case of pain, pallor or a change in skin color.
5. Document the medical opinion and a specific consent.

In areas of higher vascular risk, caution increases, and the professional should weigh whether the risk is worth it. The set of care steps after any injectable is in emergency after harmonization.

When is it better to decline?

Declining is a legitimate decision and, sometimes, the most responsible one. It makes sense when the disease is active, the doctor does not clear it, the patient has open wounds at the site, or expectations are misaligned with what the procedure can offer. Note the conversation in the patient record and offer reassessment at another time.

Where does Harmy fit in?

Harmy helps at the conversation stage: the illustrative projection shows the patient what can be planned in small volumes, which can help align expectations realistically. It does not assess the disease or replace medical clearance, and the image is always a simulation, not a promise of results.